Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Nguyen

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Communications Chemistry|January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factorsNishma Gupta, Nicole Trainor, Mona Radwan, et al.
Blood Advances|October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availabilityMarie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
Science Translational Medicine|November 19, 2016
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitorsDaniel F Ortiz, Jonathan C Lansing, Laura Rutitzky, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Cell Reports|April 11, 2019
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in CancerTu Nguyen, Brian James Kirsch, Ryoichi Asaka, et al.
American Journal of Hematology|December 23, 2015
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment studyMichael Loschi, Raphael Porcher, Fiorenza Barraco, et al.
Bone Marrow Transplantation|May 12, 2021
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working PartyPatrick J Hayden, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
Bone Marrow Transplantation|July 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Ryszard Swoboda, et al.
Communications Chemistry|January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factorsNishma Gupta, Nicole Trainor, Mona Radwan, et al.
Blood Advances|October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availabilityMarie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
Science Translational Medicine|November 19, 2016
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitorsDaniel F Ortiz, Jonathan C Lansing, Laura Rutitzky, et al.
Haematologica|April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMTJoanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Cell Reports|April 11, 2019
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in CancerTu Nguyen, Brian James Kirsch, Ryoichi Asaka, et al.
American Journal of Hematology|December 23, 2015
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment studyMichael Loschi, Raphael Porcher, Fiorenza Barraco, et al.
Bone Marrow Transplantation|May 12, 2021
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working PartyPatrick J Hayden, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Pageof 10